Business Context and Reporting Period
This Form 8-K is a Current Report filed by Intelligent Bio Solutions Inc. on April 20, 2026. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbol INBS. The filing serves to disclose a Regulation FD investor presentation and provide an update on the company's outstanding share count.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses on capital structure updates rather than operational financial performance.
- Outstanding Shares: As of April 20, 2026, the total number of outstanding shares of Common Stock is 2,176,848.
- Share Issuance Drivers: The increase in shares resulted from (a) the exercise of previously issued outstanding warrants and (b) the sale of Common Stock under the At The Market Offering Agreement dated September 18, 2024, with Ladenburg Thalmann & Co. Inc.
Material Changes
The primary material change reported is the increase in the total number of outstanding shares since the previous Current Report on Form 8-K filed on March 23, 2026. No other material changes to financial position or operations are detailed in this specific filing.
Guidance, Outlook, and Risks
The company furnished an investor presentation (Exhibit 99.1) relating to its business and operations, which is available on the company's website. However, the text of this 8-K does not contain specific guidance, outlook figures, or management commentary beyond the reference to the presentation. The filing explicitly states that the information in Item 7.01 is not deemed "filed" for purposes of the Exchange Act and is not incorporated by reference unless specifically identified.
Investor Verification Checklist
- Verify the exact number of shares issued via warrant exercises versus the At The Market Offering since March 23, 2026.
- Review the attached Exhibit 99.1 (Investor Presentation) for specific operational updates or strategic guidance not included in the 8-K text.
- Confirm the current market price and trading volume of INBS to assess the dilution impact of the 2,176,848 outstanding shares.
- Check the status of the At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. for remaining capacity.